Arylpiperazine-mediated activation of Akt protects SH-SY5Y neuroblastoma cells from 6-hydroxydopamine-induced apoptotic and autophagic death

Neuropharmacology

Volumn 72, Issue , 2013, Pages 224-235

  Tovilovic, Gordana ^a   Zogovic, Nevena ^a   Soskic, Vukic ^b   Schrattenholz, Andre ^b   Kostic Rajacic, Sladjana ^c   Misirkic Marjanovic, Maja ^a,d   Janjetovic, Kristina ^a,d   Vucicevic, Ljubica ^a,d   Arsikin, Katarina ^d   Harhaji Trajkovic, Ljubica ^a   Trajkovic, Vladimir ^d  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b PROTEOSYS AG   (Germany)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

6 Hydroxydopamine; Akt; Apoptosis; Arylpiperazine; Autophagy; Neuroprotection

Indexed keywords

1 ARYLPIPERAZINE; BAFILOMYCIN A1; JANUS KINASE; LACTATE DEHYDROGENASE; MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE ASSOCIATED PROTEIN LIGHT CHAIN 3; MITOGEN ACTIVATED PROTEIN KINASE 1; N [3 [2 (4 PHENYLPIPERAZIN 1 YL) ETHYL] PHENYL]PICOLINAMIDE; OXIDOPAMINE; PICOLINAMIDE; PIPERAZINE DERIVATIVE; PROTEIN KINASE B; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ACIDIFICATION; APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DEPOLARIZATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA FRAGMENTATION; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME RELEASE; FLOW CYTOMETRY; GENE SILENCING; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; NEUROBLASTOMA CELL; NEUROPROTECTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; UPREGULATION;

EID: 84884827950     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.04.037     Document Type: Article

References (62)

1. Abramova, N.A., Cassarino, D.S., Khan, S.M., Painter, T.W., Bennett Jr., J.P., 2002. Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma. J. Neurosci. Res. 67, 494-500. (Pubitemid 34117119)
2. Arsikin, K., Kravic-Stevovic, T., Jovanovic, M., Ristic, B., Tovilovic, G., Zogovic, N., Bumbasirevic, V., Trajkovic, V., Harhaji-Trajkovic, L., 2012. Autophagy-dependent and -independent involvement of AMP-activated protein kinase in 6- hydroxydopamine toxicity to SH-SY5Y neuroblastoma cells. Biochim. Biophys. Acta 1822, 1826-1836.
3. Batlevi, Y., La Spada, A.R., 2011. Mitochondrial autophagy in neural function, neurodegenerative disease, neuron cell death, and aging. Neurobiol. Dis. 43, 46-51.
4. Blommaart, E.F., Krause, U., Schellens, J.P., Vreeling-Sindelarova, H., Meijer, A.J., 1997. The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur. J. Biochem. 243, 240-246. (Pubitemid 27060408)
5. Blum, D., Torch, S., Lambeng, N., Nissou, M., Benabid, A.L., Sadoul, R., Verna, J.M., 2001. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 65, 135-172. (Pubitemid 32524182)
6. Boya, P., Kroemer, G., 2008. Lysosomal membrane permeabilization in cell death. Oncogene 27, 6434-6451.
7. Caccia, S., 2007. N-dealkylation of arylpiperazine derivatives: disposition and metabolism of the 1-aryl-piperazines formed. Curr. Drug Metab. 8, 612-622. (Pubitemid 47209098)
8. Chaabane, W., User, S.D., El-Gazzah, M., Jaksik, R., Sajjadi, E., Rzeszowska-Wolny, J., Los, M.J., 2013. Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer. Arch. Immunol. Ther. Exp. (Warsz) 61, 43-58.
9. Chen, Y., McMillan-Ward, E., Kong, J., Israels, S.J., Gibson, S.B., 2008. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ. 15, 171-182. (Pubitemid 350286185)
10. Cheng, H.C., Kim, S.R., Oo, T.F., Kareva, T., Yarygina, O., Rzhetskaya, M., Wang, C., During, M., Talloczy, Z., Tanaka, K., Komatsu, M., Kobayashi, K., Okano, H., Kholodilov, N., Burke, R.E., 2011. Akt suppresses retrograde degeneration of dopaminergic axons by inhibition of macroautophagy. J. Neurosci. 31, 2125-2135.
11. Cheng, W.T., Guo, Z.X., Lin, C.A., Lin, M.Y., Tung, L.C., Fang, K., 2009. Oxidative stress promotes autophagic cell death in human neuroblastoma cells with ectopic transfer of mitochondrial PPP2R2B (Bbeta2). BMC Cell Biol. 10, 91.
12. Cheung, Y.T., Lau, W.K., Yu, M.S., Lai, C.S., Yeung, S.C., So, K.F., Chang, R.C., 2009. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology 30, 127-135.
13. Choi, W.S., Yoon, S.Y., Oh, T.H., Choi, E.J., O'Malley, K.L., Oh, Y.J., 1999. Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. J. Neurosci. Res. 57, 86-94. (Pubitemid 29293582)
14. Chu, J.M., Chen, L.W., Chan, Y.S., Yung, K.K., 2011. Neuroprotective effects of neurokinin receptor one in dopaminergic neurons are mediated through Akt/PKB cell signaling pathway. Neuropharmacology 61, 1389-1398.
15. Cohen, G., Heikkila, R.E., 1974. The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J. Biol. Chem. 249, 2447-2452.
16. Connolly, D.T., Knight, M.B., Harakas, N.K., Wittwer, A.J., Feder, J., 1986. Determination of the number of endothelial cells in culture using an acid phosphatase assay. Anal. Biochem. 152, 136-140. (Pubitemid 16140445)
17. Crocker, C.E., Khan, S., Cameron, M.D., Robertson, H.A., Robertson, G.S., Lograsso, P., 2011. JNK inhibition protects dopamine neurons and provides behavioral improvement in a rat 6-hydroxydopamine model of Parkinson's disease. ACS Chem. Neurosci. 2, 207-212.
18. Dagda, R.K., Zhu, J., Kulich, S.M., Chu, C.T., 2008. Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson's disease. Autophagy 4, 770-782.
19. Dehay, B., Bove, J., Rodriguez-Muela, N., Perier, C., Recasens, A., Boya, P., Vila, M., 2010. Pathogenic lysosomal depletion in Parkinson's disease. J. Neurosci. 30, 12535-12544.
20. Dooley, C.T., Li, L., Misler, J.A., Thompson, J.H., 2012. Toxicity of 6-hydroxydopamine: live cell imaging of cytoplasmic redox flux. Cell Biol. Toxicol. 28, 89-101.
21. Druse, M., Tajuddin, N.F., Gillespie, R.A., Le, P., 2005. Signaling pathways involved with serotonin1A agonist-mediated neuroprotection against ethanol-induced apoptosis of fetal rhombencephalic neurons. Brain Res. Dev. Brain Res.159,18-28. (Pubitemid 41557710)
22. Eminel, S., Klettner, A., Roemer, L., Herdegen, T.,Waetzig, V., 2004. JNK2 translocates to the mitochondria and mediates cytochrome c release in PC12 cells in response to 6-hydroxydopamine. J. Biol. Chem. 279, 55385-55392. (Pubitemid 40066538)
23. Fei, X.F., Qin, Z.H., Xiang, B., Li, L.Y., Han, F., Fukunaga, K., Liang, Z.Q., 2009. Olomoucine inhibits cathepsin L nuclear translocation, activates autophagy and attenuates toxicity of 6-hydroxydopamine. Brain Res. 1264, 85-97.
24. Ferrari-Toninelli, G., Maccarinelli, G., Uberti, D., Buerger, E., Memo, M., 2010. Mitochondria-targeted antioxidant effects of S(-) and R(+) pramipexole. BMC Pharmacol. 10, 2.
25. Fimia, G.M., Piacentini, M., 2010. Regulation of autophagy in mammals and its interplay with apoptosis. Cell. Mol. Life Sci. 67, 1581-1588.
26. Ghavami, S., Asoodeh, A., Klonisch, T., Halayko, A.J., Kadkhoda, K., Kroczak, T.J., Gibson, S.B., Booy, E.P., Naderi-Manesh, H., Los, M., 2008. Brevinin-2R(1) semiselectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway. J. Cell. Mol. Med. 12, 1005-1022. (Pubitemid 351718078)
27. Ghavami, S., Eshragi, M., Ande, S.R., Chazin, W.J., Klonisch, T., Halayko, A.J., McNeill, K.D., Hashemi, M., Kerkhoff, C., Los, M., 2010. S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3. Cell Res. 20, 314-331.
28. Glinka, Y.Y., Youdim, M.B., 1995. Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. Eur. J. Pharmacol. 292, 329-332.
29. Gu, M., Iravani, M.M., Cooper, J.M., King, D., Jenner, P., Schapira, A.H., 2004. Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms. J. Neurochem. 91, 1075-1081. (Pubitemid 39587446)
30. Harhaji-Trajkovic, L., Vilimanovich, U., Kravic-Stevovic, T., Bumbasirevic, V., Trajkovic, V., 2009. AMPK-mediated autophagy inhibits apoptosis in cisplatintreated tumour cells. J. Cell. Mol. Med. 13, 3644-3654.
31. He, C., Klionsky, D.J., 2009. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 43, 67-93.
32. Jiang, Z., Yu, P.H., 2005. Involvement of extracellular signal-regulated kinases 1/2 and (phosphoinositide 3-kinase)/Akt signal pathways in acquired resistance against neurotoxin of 6-hydroxydopamine in SH-SY5Y cells following cell-cell interaction with astrocytes. Neuroscience 133, 405-411. (Pubitemid 40726208)
33. Kakimura, J., Kitamura, Y., Takata, K., Kohno, Y., Nomura, Y., Taniguchi, T., 2001. Release and aggregation of cytochrome c and alpha-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole. Eur. J. Pharmacol. 417, 59-67. (Pubitemid 32299869)
34. Kiffin, R., Bandyopadhyay, U., Cuervo, A.M., 2006. Oxidative stress and autophagy. Antioxid. Redox Signal. 8, 152-162. (Pubitemid 43324542)
35. Klionsky, D.J., Elazar, Z., Seglen, P.O., Rubinsztein, D.C., 2008. Does bafilomycin A1 block the fusion of autophagosomes with lysosomes? Autophagy 4, 849-950.
36. Koprivica, V., Regardie, K., Wolff, C., Fernalld, R., Murphy, J.J., Kambayashi, J., Kikuchi, T., Jordan, S., 2011. Aripiprazole protects cortical neurons from glutamate toxicity. Eur. J. Pharmacol. 651, 73-76.
37. Kulich, S.M., Horbinski, C., Patel, M., Chu, C.T., 2007. 6-Hydroxydopamine induces mitochondrial ERK activation. Free Radic. Biol. Med. 43, 372-383. (Pubitemid 46977632)
38. Kwon, S.H., Hong, S.I., Jung, Y.H., Kim, M.J., Kim, S.Y., Kim, H.C., Lee, S.Y., Jang, C.G., 2012. Lonicera japonica THUNB. protects 6-hydroxydopamine- induced neurotoxicity by inhibiting activation of MAPKs, PI3K/Akt, and NF-kappaB in SH-SY5Y cells. Food Chem. Toxicol. 50, 797-807.
39. Lee, J., Giordano, S., Zhang, J., 2012. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem. J. 441, 523-540.
40. Lee, J.A., 2012. Neuronal autophagy: a housekeeper or a fighter in neuronal cell survival? Exp. Neurobiol. 21, 1-8.
41. Li, L., Wang, X., Fei, X., Xia, L., Qin, Z., Liang, Z., 2011. Parkinson's disease involves autophagy and abnormal distribution of cathepsin L. Neurosci. Lett. 489, 62-67.
42. Lotharius, J., Dugan, L.L., O'Malley, K.L., 1999. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J. Neurosci. 19, 1284-1293. (Pubitemid 29088911)
43. Marin, C., Aguilar, E., 2011. In vivo 6-OHDA-induced neurodegeneration and nigral autophagic markers expression. Neurochem. Int. 58, 521-526.
44. Matsuo, T., Izumi, Y., Kume, T., Takada-Takatori, Y., Sawada, H., Akaike, A., 2010. Protective effect of aripiprazole against glutamate cytotoxicity in dopaminergic neurons of rat mesencephalic cultures. Neurosci. Lett. 481, 78-81.
45. Park, S.W., Lee, C.H., Lee, J.G., Kim, L.W., Shin, B.S., Lee, B.J., Kim, Y.H., 2011. Protective effects of atypical antipsychotic drugs against MPP(+)-induced oxidative stress in PC12 cells. Neurosci. Res. 69, 283-290.
46. Park, S.W., Lee, J.G., Ha, E.K., Choi, S.M., Cho, H.Y., Seo, M.K., Kim, Y.H., 2009. Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5Y cells. Eur. Neuropsychopharmacol. 19, 356-362.
47. Puttonen, K.A., Lehtonen, S., Lampela, P., Mannisto, P.T., Raasmaja, A., 2008. Different viabilities and toxicity types after 6-OHDA and Ara-C exposure evaluated by four assays in five cell lines. Toxicol. In Vitro 22, 182-189. (Pubitemid 350267099)
48. Raicevic, N., Mladenovic, A., Perovic, M., Harhaji, L., Miljkovic, D., Trajkovic, V., 2005. Iron protects astrocytes from 6-hydroxydopamine toxicity. Neuropharmacology 48, 720-731. (Pubitemid 40462411)
49. Ramirez, A.D., Wong, S.K., Menniti, F.S., 2003. Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms. Eur. J. Pharmacol. 475, 29-35. (Pubitemid 37088003)
50. Saner, A., Thoenen, H., 1971. Model experiments on the molecular mechanism of action of 6-hydroxydopamine. Mol. Pharmacol. 7, 147-154.
51. Smolewski, P., Grabarek, J., Phelps, D.J., Darzynkiewicz, Z., 2001. Stathmo-apoptosis: arresting apoptosis by fluorochrome-labeled inhibitor of caspases. Int. J. Oncol. 19, 657-663.
52. Storch, A., Kaftan, A., Burkhardt, K., Schwarz, J., 2000. 6-Hydroxydopamine toxicity towards human SH-SY5Y dopaminergic neuroblastoma cells: independent of mitochondrial energy metabolism. J. Neural Transm. 107, 281-293. (Pubitemid 30162690)
53. Tiong, C.X., Lu, M., Bian, J.S., 2010. Protective effect of hydrogen sulphide against 6- OHDA-induced cell injury in SH-SY5Y cells involves PKC/PI3K/Akt pathway. Br. J. Pharmacol. 161, 467-480.
54. Tovilovic, G., Zogovic, N., Harhaji-Trajkovic, L., Misirkic-Marjanovic, M., Janjetovic, K., Vucicevic, L., Kostic-Rajacic, S., Schrattenholz, A., Isakovic, A., Soskic, V., Trajkovic, V., 2012. Arylpiperazine dopamineric ligands protect neuroblastoma cells from nitric oxide (NO)-induced mitochondrial damage and apoptosis. ChemMedChem 7, 495-508.
55. Wang, J., Whiteman, M.W., Lian, H., Wang, G., Singh, A., Huang, D., Denmark, T., 2009. A non-canonical MEK/ERK signaling pathway regulates autophagy via regulating Beclin 1. J. Biol. Chem. 284, 21412-21424.
56. Xilouri, M., Stefanis, L., 2010. Autophagy in the central nervous system: implications for neurodegenerative disorders. CNS Neurol. Disord. Drug Targets 9, 701-719.
57. Xilouri, M., Stefanis, L., 2011. Autophagic pathways in Parkinson disease and related disorders. Expert Rev. Mol. Med. 13, e8.
58. Yoon, J., Bang, S.H., Park, J.S., Chang, S.T., Kim, Y.H., Min, J., 2011. Increased in vitro lysosomal function in oxidative stress-induced cell lines. Appl. Biochem. Biotechnol. 163, 1002-1011.
59. Yorimitsu, T., Klionsky, D.J., 2005. Autophagy: molecular machinery for self-eating. Cell Death Differ. 12 (Suppl. 2), 1542-1552. (Pubitemid 41553991)
60. Zhang, X., Tang, N., Hadden, T.J., Rishi, A.K., 2011. Akt, FoxO and regulation of apoptosis. Biochim. Biophys. Acta 1813, 1978-1986.
61. Zhao, H., Kalivendi, S., Zhang, H., Joseph, J., Nithipatikom, K., Vasquez-Vivar, J., Kalyanaraman, B., 2003. Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide. Free Radic. Biol. Med. 34, 1359-1368. (Pubitemid 36570409)
62. Zorov, D.B., Juhaszova, M., Sollott, S.J., 2006. Mitochondrial ROS-induced ROS release: an update and review. Biochim. Biophys. Acta 1757, 509-517.